SOURCE: VFemina

VFemina

August 12, 2016 09:37 ET

VFemina Commends Announcement of FemiLift Clinical Study

Cleveland Clinic and Alma Lasers Launch Research on Treatment of Vaginal Dryness With Laser Technology

CHICAGO, IL--(Marketwired - August 12, 2016) - VFemina, the only group of Obstetrician/Gynecologists in the State of Illinois to provide the FemiLift procedure, applauded the recent announcement of a clinical study by the Cleveland Clinic. This advanced laser technology designed for vaginal rejuvenation has demonstrated results in treating vaginal dryness, eliminating urinary stress incontinence and improving sexual enjoyment. Alma Lasers, the manufacturers of FemiLift, is sponsoring the Cleveland Clinic's clinical trial specifically to assess the use of the FemiLift laser to treat vaginal dryness in postmenopausal women.

The clinical study kicked off in May 2016 and recruited healthy, non-smoking postmenopausal women between the ages of 35 and 70. The purpose of the study, which will run through March 2017, is to evaluate changes in vaginal dryness using the FemiLift laser, a 10-minute, non-invasive, pain-free laser treatment.

"The clinical study is wonderful news for women who have been frustrated with the current options available to treat common symptoms that accompany menopause," stated Dr. David Preskill, an OB/GYN in Chicago and Libertyville, Illinois who has performed more than 50 FemiLift procedures on patients. "Patients have reported not only relief from painful sex and dryness, but they have also noticed a reduction and sometimes complete relief from urinary stress incontinence," he added.

Studies show that nearly 50% of postmenopausal women experience symptoms of vulvovaginal atrophy, a common and underreported condition associated with decreased estrogenization of vaginal tissue. The FemiLift Procedure may be a viable non-surgical and non-hormonal solution to treat symptoms such as dryness, irritation, painful intercourse, urge incontinence and urinary frequency. The treatment may also be ideal for women who have experienced vaginal atrophy after breast or ovarian cancer and cannot take vaginal estrogen.

VFemina's OB/GYNs' Dr. David Preskill and Dr. Joyce Chams have been successfully treating patients with FemiLift to relieve the symptoms of stress urinary incontinence (the involuntary leaking of urine while exercising, laughing, coughing or sneezing), as well as vaginal looseness and dryness. Their findings, for both pre and post-menopausal women, indicate that this new minimally invasive laser technology is remarkably effective with many patients, providing immediate, positive results. The Cleveland Clinic study is expected to confirm what the VFemina doctors have observed.

"Women deserve effective, non-surgical treatment for their intimate and sexual health. We don't have to just live with it, or tolerate discomfort," said Dr. Joyce Chams a VFemina OB/GYN in Glenview. "We plan to continue to deliver this treatment to patients throughout the course of the Cleveland Clinic study and eagerly await the results, so that this procedure can be more readily available to all women," she added.

For more information about FemiLift, or to make an appointment with a VFemina OB/GYN call 847-362-0100 or visit VFemina.com

Contact Information